These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16737760)

  • 1. QSAR study for a novel series of ortho disubstituted phenoxy analogues of alpha1-adrenoceptor antagonist WB4101.
    Pallavicini M; Fumagalli L; Gobbi M; Bolchi C; Colleoni S; Moroni B; Pedretti A; Rusconi C; Vistoli G; Valoti E
    Eur J Med Chem; 2006 Sep; 41(9):1025-40. PubMed ID: 16737760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR study for a novel series of ortho monosubstituted phenoxy analogues of alpha1-adrenoceptor antagonist WB4101.
    Fumagalli L; Bolchi C; Colleoni S; Gobbi M; Moroni B; Pallavicini M; Pedretti A; Villa L; Vistoli G; Valoti E
    Bioorg Med Chem; 2005 Apr; 13(7):2547-59. PubMed ID: 15755656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).
    Pallavicini M; Budriesi R; Fumagalli L; Ioan P; Chiarini A; Bolchi C; Ugenti MP; Colleoni S; Gobbi M; Valoti E
    J Med Chem; 2006 Nov; 49(24):7140-9. PubMed ID: 17125266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective α1D-adrenoceptor antagonist.
    Fumagalli L; Pallavicini M; Budriesi R; Bolchi C; Canovi M; Chiarini A; Chiodini G; Gobbi M; Laurino P; Micucci M; Straniero V; Valoti E
    J Med Chem; 2013 Aug; 56(16):6402-12. PubMed ID: 23902232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of alpha 1 antagonist WB-4101.
    Bolchi C; Catalano P; Fumagalli L; Gobbi M; Pallavicini M; Pedretti A; Villa L; Vistoli G; Valoti E
    Bioorg Med Chem; 2004 Sep; 12(18):4937-51. PubMed ID: 15336273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.
    Quaglia W; Santoni G; Pigini M; Piergentili A; Gentili F; Buccioni M; Mosca M; Lucciarini R; Amantini C; Nabissi MI; Ballarini P; Poggesi E; Leonardi A; Giannella M
    J Med Chem; 2005 Dec; 48(24):7750-63. PubMed ID: 16302814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective α1B-adrenoceptor antagonist.
    Fumagalli L; Pallavicini M; Budriesi R; Gobbi M; Straniero V; Zagami M; Chiodini G; Bolchi C; Chiarini A; Micucci M; Valoti E
    Eur J Med Chem; 2012 Dec; 58():184-91. PubMed ID: 23124215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New 1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives: analogues of HEAT as ligands for the alpha1-adrenergic receptor subtypes.
    Romeo G; Materia L; Pittalà V; Modica M; Salerno L; Siracusa M; Russo F; Minneman KP
    Bioorg Med Chem; 2006 Aug; 14(15):5211-9. PubMed ID: 16647264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
    J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular properties of the WB4101 enantiomers and of its chiral methyl derivatives for alpha 1-adrenoceptor recognition.
    Villa L; Valoti E; Villa AM; Pallavicini M; Ferri V; Iuliano E; Brunello N
    Farmaco; 1994 Sep; 49(9):587-606. PubMed ID: 7811353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel adrenoceptor antagonists with a tricyclic pyrrolodipyridazine skeleton.
    Barlocco D; Cignarella G; Montesano F; Leonardi A; Mella M; Toma L
    J Med Chem; 1999 Jan; 42(1):173-7. PubMed ID: 9888842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and α1-adrenoceptor antagonist activity of tamsulosin analogues.
    Sagratini G; Angeli P; Buccioni M; Gulini U; Marucci G; Melchiorre C; Poggesi E; Giardinà D
    Eur J Med Chem; 2010 Dec; 45(12):5800-7. PubMed ID: 20934789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Campillo M; Pardo L; Delgado M; Manzanares J; Fuentes JA
    J Med Chem; 2005 Apr; 48(7):2548-58. PubMed ID: 15801844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.
    Leonardi A; Motta G; Boi C; Testa R; Poggesi E; De Benedetti PG; Menziani MC
    J Med Chem; 1999 Feb; 42(3):427-37. PubMed ID: 9986714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CoMFA methodology in structure-activity analysis of hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives based on affinity towards 5-HT1A, 5-HT2A and alpha1-adrenergic receptors.
    Maciejewska D; Zołek T; Herold F
    J Mol Graph Model; 2006 Nov; 25(3):353-62. PubMed ID: 16542863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-activity relationship study of novel alpha1a-selective adrenoceptor antagonists.
    Singh P; Kumar R
    J Enzyme Inhib; 2001 Oct; 16(4):331-8. PubMed ID: 11916138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.
    Handzlik J; Maciag D; Kubacka M; Mogilski S; Filipek B; Stadnicka K; Kieć-Kononowicz K
    Bioorg Med Chem; 2008 Jun; 16(11):5982-98. PubMed ID: 18490167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation on human skin fibroblast by alpha1 adrenergic receptor subtypes.
    Sterin-Borda L; Furlan C; Orman B; Borda E
    Biochem Pharmacol; 2007 Nov; 74(9):1401-12. PubMed ID: 17714696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic-function-approximation-based QSAR model for the affinity of arylpiperazines toward alpha1 adrenoceptors.
    Maccari L; Magnani M; Strappaghetti G; Corelli F; Botta M; Manetti F
    J Chem Inf Model; 2006; 46(3):1466-78. PubMed ID: 16711766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 3-arylpiperazinylalkylpyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as novel, potent, and selective alpha1-adrenoceptor ligands.
    Patanè E; Pittalà V; Guerrera F; Salerno L; Romeo G; Siracusa MA; Russo F; Manetti F; Botta M; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2005 Apr; 48(7):2420-31. PubMed ID: 15801833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.